• Tin Mesoporphyrin IX: A Causal HO-1 Probe

  2026-09-16

  Tin Mesoporphyrin IX (chloride) enables causal interrogation of heme oxygenase signaling rather than simple pathway correlation. This article connects its biochemical selectivity with HO-1/ROS findings in hepatitis B research and outlines assay decisions for metabolic disease research.

• I-BET-762: BET Inhibitor for Ferroptosis

  2026-09-16

  I-BET-762 is a selective BET inhibitor that connects epigenetic control with ferroptosis susceptibility. This article translates BRD4, ROS, and FSP1 findings into practical assay decisions for inflammation and cancer biology research.

• Palmitic acid (N2456): Protocol and QC Guide

  2026-09-15

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid input for solvent-based studies of lipid metabolism, insulin signaling, inflammation, and protein palmitoylation. It is insoluble in water and is not intended for direct aqueous addition or long-term solution storage, so fresh preparation, solvent controls, and documented QC are essential.

• Grazoprevir/Elbasvir: Evidence from HCV Literature

  2026-09-15

  The reference review explains how combining the NS3/4A protease inhibitor grazoprevir with the NS5A inhibitor elbasvir created a potent interferon-free strategy for chronic HCV infection. Its main practical contribution is the integration of efficacy, safety, resistance, pharmacology, and difficult-to-treat subgroup evidence into a framework for interpreting genotype- and patient-specific treatment decisions.

• APOL1 Evolution, Isoforms, and APOL3 Interaction

  2026-09-14

  The 2025 Cells study integrates population genetics, splice-isoform biology, and APOL1–APOL3 interaction analysis to refine models of APOL1-associated cellular injury. Its main contribution is a multidomain framework showing why renal toxicity cannot be interpreted from APOL1 risk variants alone, without considering haplotype context, isoform identity, and protein partners.

• Quizartinib (AC220) FLT3 Assay Workflows

  2026-09-14

  Build cleaner FLT3-dependent AML experiments with Quizartinib (AC220), from low-nanomolar pathway inhibition to translational xenograft studies. This guide emphasizes dosing logic, phospho-FLT3 readouts, resistance modeling, and troubleshooting for reproducible results.

• BMS-345541 hydrochloride: IKK Assay Guide

  2026-09-13

  Use BMS-345541 hydrochloride as a selective IKK inhibitor to separate NF-κB-dependent inflammatory signaling from downstream cell-death phenotypes. This workflow combines concentration, solubility, timing, and orthogonal readout guidance for inflammation research, T-ALL models, and RIPK1-focused experiments.

• Artemisinin, NRF2, and Ferroptosis in Diabetic Cognition

  2026-09-12

  Wang et al. showed that artemisinin improved learning and memory in streptozotocin-induced type 2 diabetes mellitus mice while reducing hippocampal oxidative injury and ferroptosis-related changes. Pharmacological blockade of NRF2 with ML385 and induction of ferroptosis with erastin weakened these benefits, supporting an NRF2-dependent mechanism that links redox control to diabetic cognitive dysfunction.

• Bromodomain Inhibitor, (+)-JQ1: Assay Guide

  2026-09-11

  A practical, scenario-based guide to using Bromodomain Inhibitor, (+)-JQ1 (SKU A1910) in viability, proliferation, and apoptosis workflows. It connects BET biology with solvent control, time-course design, endpoint selection, data interpretation, and research-grade product selection.

• ML365: TASK1 Inhibitor for Ion Channel Research

  2026-09-11

  ML365, also known as 2-methoxy-N-(3-(3-methylbenzamido)phenyl)benzamide, is a potent TASK1 potassium channel inhibitor with nanomolar assay activity. Product data and a 2024 aged-mouse study support its use in ion channel pharmacology research and exploratory neuroinflammation experiments, while direct TASK1 causality in postoperative cognitive impairment remains unproven.

• FerroOrange: Translating Fe²⁺ Signals in Ferroptosis

  2026-09-10

  Ferroptosis is not simply an endpoint of neuronal injury; it is a dynamic intersection of iron handling, lipid damage, inflammation, and cellular stress. This thought-leadership guide explains how FerroOrange can help translational researchers connect live-cell Fe²⁺ measurements with the Cdk5–AMPK evidence emerging from ischemic-stroke models, while preserving appropriate assay boundaries.

• Isochlorogenic Acid A Disrupts the HBV Life Cycle

  2026-09-10

  The reference study shows that isochlorogenic acid A suppresses hepatitis B virus replication through coordinated effects on HO-1-mediated reactive oxygen species regulation, viral gene expression, cccDNA-associated signals, capsid formation, and envelopment. Its value lies in connecting redox biology with several distinct stages of HBV morphogenesis, while also defining experimental readouts for testing this mechanism.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance

  2026-09-09

  This study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA. Its integrated clinical, multi-omic, biochemical, and animal-model evidence defines an RCN2–UBR5–PPP2CA–PI3K-AKT axis that may help explain treatment failure in advanced ESCC.

• SM-102 for mRNA Delivery: Practical LNP Guide

  2026-09-09

  SM-102 offers a practical ionizable-lipid starting point for lipid nanoparticle workflows spanning mRNA vaccine development, cell assays, and formulation screening. This guide connects product handling, reproducible mixing, data-driven comparison, and troubleshooting so researchers can separate lipid performance from process variability.

• Lipo3K Transfection Reagent for GBM Assays

  2026-09-08

  Use Lipo3K Transfection Reagent to build efficient PXDN knockdown, LDHA rescue, and DNA–siRNA co-transfection workflows in glioblastoma models. Its low-toxicity profile, enhancer option for plasmids, and compatibility with serum-containing media help connect mechanistic gene studies with reproducible metabolic assays.

8145 records 1/543 page Next 12345 下5页 Last page